FDA links once-promising pain drugs to bone decay

FDA links once-promising pain drugs to bone decay
Some of the world's largest drugmakers will face an uphill battle next week in their bid to revive a class of experimental pain drugs that have been sidelined by safety concerns for nearly two years.
Source: news.yahoo.com